activins has been researched along with Melanoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Avilés-Izquierdo, JA; Barrio-Alonso, C; García-Martínez, E; Gutiérrez-Seijo, A; Parra-Blanco, V; Samaniego, R; Sánchez-Mateos, P | 1 |
| Constam, DB; Donovan, P; Dubey, OA; Kallioinen, S; Muehlethaler, K; Müller, P; Rimoldi, D; Rogers, KW | 1 |
| Ko, J; Lee, J; Yi, JY | 1 |
| Bodenstine, TM; Gilgur, A; Hendrix, MJ; Hinck, AP; Khalkhali-Ellis, Z; Kirschmann, DA; Seftor, EA | 1 |
| Funaba, M; Matsuzaki, F; Murakami, M | 1 |
| Bracke, M; Devreese, B; Mareel, M; Stove, C; Van Beeumen, J; Vanrobaeys, F | 1 |
6 other study(ies) available for activins and Melanoma
| Article | Year |
|---|---|
Activin A Sustains the Metastatic Phenotype of Tumor-Associated Macrophages and Is a Prognostic Marker in Human Cutaneous Melanoma.
Topics: Activins; Animals; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mice; Phenotype; Prognosis; Skin Neoplasms; Tumor Microenvironment; Tumor-Associated Macrophages | 2022 |
Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion.
Topics: Activins; Animals; Cachexia; Cell Cycle; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immune Evasion; Immune System; Ki-67 Antigen; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; Phenotype; Signal Transduction; Skin Neoplasms; Tumor Microenvironment | 2017 |
Histone deacetylase inhibitor (HDACi) upregulates activin A and activates the Smad signaling pathway in melanomas.
Topics: Acetylation; Activins; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Separation; Culture Media, Conditioned; Cyclin-Dependent Kinase Inhibitor p21; Flow Cytometry; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Melanoma; RNA, Messenger; Signal Transduction; Smad Proteins, Receptor-Regulated; Up-Regulation; Vorinostat | 2018 |
Divergence(s) in nodal signaling between aggressive melanoma and embryonic stem cells.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Activins; Blotting, Western; Cells, Cultured; Embryonic Stem Cells; Humans; Melanoma; Nodal Protein; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Skin Neoplasms; Transforming Growth Factor beta | 2015 |
Regulation of melanin synthesis by the TGF-beta family in B16 melanoma cells.
Topics: Activins; Bone Morphogenetic Protein 2; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Membrane Glycoproteins; Monophenol Monooxygenase; Oxidoreductases; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2009 |
Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition.
Topics: Activin Receptors; Activins; Amino Acid Sequence; Annexin A5; Apoptosis; Blotting, Western; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Follistatin; Genes, Reporter; Humans; Immunoblotting; Ligands; Luciferases; Mass Spectrometry; Melanocytes; Melanoma; Molecular Sequence Data; Phosphorylation; Protein Structure, Tertiary; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Time Factors | 2004 |